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Abstract: Marine sponges and cyanobacteria have a long history of co-evolution, with documented
genome adaptations in cyanobionts. Both organisms are known to produce a wide variety of natural
compounds, with only scarce information about novel natural compounds produced by cyanobionts.
In the present study, we aimed to address their toxicological potential, isolating cyanobacteria
(n = 12) from different sponge species from the coast of Portugal (mainland, Azores, and Madeira
Islands). After large-scale growth, we obtained both organic and aqueous extracts to perform a
series of ecologically-relevant bioassays. In the acute toxicity assay, using nauplii of Artemia salina,
only organic extracts showed lethality, especially in picocyanobacterial strains. In the bioassay with
Paracentrotus lividus, both organic and aqueous extracts produced embryogenic toxicity (respectively
58% and 36%), pointing to the presence of compounds that interfere with growth factors on cells.
No development of pluteus larvae was observed for the organic extract of the strain Chroococcales
6MA13ti, indicating the presence of compounds that affect skeleton formation. In the hemolytic assay,
none of the extracts induced red blood cells lysis. Organic extracts, especially from picoplanktonic
strains, proved to be the most promising for future bioassay-guided fractionation and compounds
isolation. This approach allows us to classify the compounds extracted from the cyanobacteria into
effect categories and bioactivity profiles.
Keywords: marine cyanobacteria; cyanotoxins; marine sponges; secondary metabolites; marine
natural compounds; bioassays; Artemia salina; Paracentrotus lividus; hemolytic essay
Key Contribution: Marine sponges were used as a source for harvesting cyanobacteria. Being adapt
to life inside sponges; these cyanobacteria can prove to have novel compounds produced from their
secondary metabolism.
1. Introduction
Cyanobacteria are photosynthetic prokaryotes, with a high morphological, physiological,
and metabolic diversity, with fossil records dating back to 3.5 billion years ago [1]. Secondary metabolite
production was essential for their survival allowing for adaptation to several environmental conditions
such as variations in temperature, pH, salinity, UV radiation, etc.
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Climate change and eutrophication increased the occurrence and frequency of cyanobacterial
blooms in water bodies [2], posing human and animals’ health risks due to toxin production.
Apart from toxin production, these secondary metabolites have also been shown to be a source
of compounds of interest in different industries, such as pharmaceutical, cosmetics, agriculture, energy,
etc. In the last decade alone, estimations point to more than 400 new natural compounds extracted from
marine cyanobacteria [3]. Coastal water blooms pose another health risk concerning cyanobacterial
toxins, as many of them are able to accumulate in both vertebrates and invertebrates [4].
Assessing marine cyanobacterial diversity on the Portuguese coast has already been the
focus of various studies (e.g., [5,6]), with Cyanobium, Leptolyngbya and Pseudanabaena as the most
abundant genera among isolates [6]. Isolated strains from the coast of Portugal were found to be
a source of bioactive compounds, both with toxicological and/or pharmaceutical interest [2,7–13].
Also, Brito et al. [14] evaluated the potential to produce secondary metabolites for some strains through
molecular methods.
In marine environments, cyanobacteria are known to form associations with a variety of
invertebrates, such as sponges (Phylum Porifera). Sponges are filter-feeders, capable of filtering
thousands of liters of water per day. During this process, some filtered microorganisms can become
part of the sponge microbiota. Sponge microbiota diversity can reach up to 4 orders of magnitude,
when compared to the one from water column [15]. In temperate ecosystems, it is estimated that
45–60% of sponges have cyanobacterial symbionts (cyanobionts) [16], and are able to cover up to 50%
of the sponge cell volume [17]. As they are able to concentrate microorganisms, sponges can be used
as a source for cyanobacteria harvesting as already stated by Regueiras, et al. [18]. Sponges are a
huge source of bioactive compounds [19], most of them known to be produced by their symbiotic
microorganisms [15]. Actinobacteria, Cyanobacteria, Firmicutes, and Proteobacteria (alpha and gamma
classes) are the main phyla producing secondary metabolites in sponges [20].
Both coccoid and filamentous cyanobacteria have been described in sponges. Recently,
Konstantinou, et al. [21] made a review on the diversity of both sponge species harboring cyanobacteria,
and cyanobacterial diversity. In Portugal, Xenococcus-like and Acaryochloris sp. were reported from
the intertidal marine sponge Hymeniacidon perlevis [22,23]. Regueiras, et al. [18] were also able to
identify cyanobacteria belonging to the genera Synechococcus, Cyanobium, Synechocystis, Nodosilinea,
Pseudanabaena, Phormidesmis, Acaryochloris, and Prochlorococcus associated with the same marine sponge.
Due to a long evolutionary history of both cyanobacteria and marine sponges, co-evolution has
already been documented, with some cyanobacteria being passed to new sponge generations through
vertical transmission (from sponge to offspring through reproductive cells) [24]. The study of genomes
from the symbiotic cyanobacteria “Ca. Synechococcus spongiarum” and its comparison with the genome
of free-living ones, found adaptations to life inside sponges and the presence of different adaptations
in different phylotypes [25,26]. These adaptations may also lead to the production of novel and unique
natural compounds.
Bioassay-guided fractionation is a successful strategy in the isolation and discovery of novel
compounds [27–31]. To address toxin production, several assays can be used. The use of the
brine shrimp Artemia salina, has ecological relevance in marine ecosystems, as these organisms
are a representation of the zooplankton community and vital on the ecology of seashores [11].
For preliminary toxicity assessment, the brine shrimp lethality assay is a standardized bioassay
in marine and aquatic research [32]. For embryogenesis studies, the use of echinoids, such as
the sea urchin Paracentrotus lividus, is very common. They occupy an important phylogenetic
position (deuterostomes) when compared to other invertebrates {Lopes, 2010 #555227}. P. lividus
are also common among the Portuguese seashore and key elements on their habitats [11], capable of
producing a great amount of eggs feasible to be fertilized in seawater, and to develop optically clear
embryos [33]. Apart from these common assays, less is known on hemolytic toxins from cyanobacteria.
Cyanobacterial toxins are able to accumulate in marine vertebrate and invertebrates [34,35], posing
risks for mammals, showing the importance of the use of such assays.
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The present study aims to do a preliminary assessment on the cyanotoxin potential of marine
cyanobacteria isolated from marine sponges. Most studies isolate marine cyanobacteria through
filtration of large volumes of water, or by scratching coastal surfaces. In the present study, we aimed to
isolate cyanobacteria from marine sponges off the coast of Portugal, as they are able to concentrate
microorganisms, allowing them to obtain some cyanobacteria that can be present in seawater in
amounts under detection. We intend to evaluate the toxic effects of organic (lipophilic) and aqueous
(hydrophilic) crude extracts towards the nauplii of the brine shrimp A. salina and embryos of the sea
urchin P. lividus, and their hemolytic activity. These assays will be useful to evaluate cyanobacterial
potential to produce compounds with relevant bioactivity profiles to be further investigated and
possibly identified in the future. This approach allow us to classify the compounds extracted from the
cyanobacteria into effect categories and bioactivity profiles.
2. Results
2.1. Acute Toxicity Assay Using Nauplii of Artemia Salina
Aqueous extracts, containing the hydrophilic compounds from the cyanobacterial strains, did not
exhibit statistically significant differences against control, in the bioassay to assess mortality in
Artemia salina nauplii (Figure 1). However, for the organic extracts, toxicity was found after 48 h
of exposure. Cyanobacterial strains Synechoccocus sp. LEGE11381 (F = 68.80, p < 0.000), Synechocystis
sp. 44B13pa (F = 21.82, p < 0.048), unidentified filamentous Synechococcales LEGE11384 (F = 24.74,
p < 0.018), Chroococales 6MA13ti (F = 86.73, p < 0.000), and Cyanobium sp. LEGE10375 (F = 43.50,
p < 0.000) presented statistically significant differences when compared against the negative control.
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Figure 1. Mortality rate (%) for the Artemia salina bioassay, after 48 h of exposure, for the orga ic and
aqueous extracts. Controls used included filtered seawater with 0.1% DMSO for negative control and
potassium dichromate (8 µg/mL) for positive control. a Assay not performed; * Statistically significant
differences between extract and control.
2.2. Embryo—Larval Acute Toxicity Assay with Paracentrotus Lividus
The toxicity of the cya oba t rial xtracts in the bioassay with P. lividus was determined by
analysis of the embryogenic success, i.e., the ability of the f rtiliz d egg to rea h the s age f pluteus
larvae, and through growth of pluteus larvae (Figure 2). Development arrest indicates that no normal
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pluteus larvae were produced. The results gathered after 48 h of incubation with cyanobacterial
extracts revealed that in the control, 67.5 ± 6.1% of the sea urchin fertilized eggs developed to normal
pluteus larvae, with an average length of 330.0 ± 18.8 µm. Figure 3 shows significant difference in the
embryogenic development, at p < 0.05, for the organic extract of the following strains: Synechococcus
sp. LEGE11381 (F = −62.78, p < 0.000), Synechocystis sp. 44B13pa (F = −41.80, p < 0.000), unidentified
filamentous Synechococcales LEGE11384 (F = −36.05, p < 0.000), Phormidium sp. 25J12tp (F = −27.22,
p < 0.010), Leptolyngbya sp. 31H12hpa (F = 67.48, p < 0.048), and Cyanobium sp. LEGE10375 (F = −52.38,
p < 0.000). The organic extract of the strain Chroococcales 6MA13ti caused development arrest with
none of the larvae reaching the stage of viable pluteus. Amongst the aqueous extracts, unidentified
filamentous Synechococcales LEGE11384 (F = −41.75, p < 0.001), Phormidium sp. 25J12tp (F = −28.75,
p < 0.033), Chroococcales 6MA13pi (F = −30.00, p < 0.024), and Cyanobacterium 34C12sp (F = −39.25,
p < 0.002) strains presented significant embryogenic effect. Regarding the results from the positive
control, only embryos on gastrula stage were found.
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Figure 3. Percentage of pluteus larvae devel e (e bryogenic success) after exposure to aqueous
and organic extracts of the cyanobacterial strains. For the controls, filtered seawater was used with
0.1% DMSO (negative) and potassium dichromate at 4 µg/mL (positive). a Assay not performed;
* Statistically significant differences between extract and control.
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Regarding larval growth data, no significant changes in larval length was observed in the aqueous
extracts at p < 0.05 [F (11, 36) = 1.039, p < 0.434)] (Figure 4). However, differences in larval length were
found in organic extracts. These differences were more significant in Synechococcus sp. LEGE11381
(246.2 ± 11.5 µm, p < 0.001) and Cyanobium sp. LEGE10375 (325.7 ± 9.7 µm, p < 0.000).
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2.3. Hemolytic Assay
The hemolytic activity registered during the assay was below 10%, with the highest value obtained
being 7% of activity by the strain Chroococcales 6MA13ti, in the organic extract. All strains and extracts
did not present significant interference with the hemoglobin content.
3. Discussion
To date, most studies exploring the bioactivity of marine cyanobacteria have been focusing on
free-living forms. Cy nobacteria can live in ssociation with a variety of marine invertebrates, such as
sponges, for example, and it is kn wn that cyanobacteria can aff ct the biosynthesis of c mpounds
from th host [36] and that symbionts have specific adaptations in their genome [25,26]. The biological
potential of associated and/or symbiotic cyanobacteria is still mostly unexplored. In the present study,
twelve marine cyanobacterial strains were isolated from sponges of the Portuguese coast. Aqueous and
organic crude extracts of the isolated cyanobacterial strains were submitted to ecologically-relevant
bioassays in order to do a preliminary assessment on the production of secondary metabolites with
relevant bioactivity profiles.
Artemia spp. is known for its ability to adapt to different environmental conditions, making
it a crucial test organism in c toxicology [37]. Results from the bioassay with the brine shrimp
Artemia salina auplii did not demonstrate acute toxicity with exp sure to the aqueous extracts of the
tested cyanobacterial strains. The organic extracts of Synechococcus sp. LEGE11381, Synechocystis sp.
44B13pa, unidentified filamentous Synechococcales LEGE11384, Chroococcales 6MA13ti, and Cyanobium
sp. LEGE10375 cyanobacterial strains proved to be the most toxic to this crustacean species. In contrast
with our results, most previous studies with cyanobacteria from the coast of Portugal found aqueous
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extracts to be more toxic. For example, Leão, et al. [10] reported lethality towards A. salina, in aqueous
extracts in free-living forms from Nodosilinea, Leptolyngbya, and Pseudanabaena genera strains. Also,
Frazão, et al. [2] found aqueous extracts of the genera Cyanobium, Synechococcus, Leptolyngbya,
Oscillatoria, and Phormidium more toxic than organic ones. In brackish waters Lopes, et al. [33]
also found aqueous extracts more toxic, and organic extracts did not induce more than 7% of mortality
on A. salina. Organic extracts in our work showed a higher toxicity towards A. salina, leading to an
assumption that cyanobacteria associated with marine sponges may produce different metabolites
from the ones present in free-living forms of cyanobacteria, and therefore, their toxicological and
pharmaceutical potential should be further investigated. The higher values of mortality here observed
were all in picocyanobacterial strains. Costa, et al. [9] already reported the potential of these
cyanobacteria as a source for novel metabolites. In the present work, toxicity was only found after 48 h.
In the bioassay with sea urchin Paracentrotus lividus, embryogenic toxicity occurred in 58% of the
organic extracts and in 36% of the aqueous extracts tested. The unidentified filamentous Synechococcales
LEGE11384, Phormidium sp. 25J12tp, Chroococcales 6MA13ti cyanobacterial strains demonstrated
embryogenic toxicity in both extracts, which may lead us to infer that, for the same cyanobacterial strain,
chemically different bioactive compounds are produced, having the same effect on the embryogenic
activity of the sea urchin. Although the Synechocystis sp. 44B13pa, unidentified filamentous
Synechococcales LEGE11384, Phormidium sp. 25J12tp, Leptolyngbya sp. 31H12hpa, Chroococcales 6MA13pi
and Cyanobacterium 34C12sp cyanobacterial strains have demonstrated to be embryotoxic, no alteration
on larval length was observed. This may suggest that the toxicity showed by these cyanobacterial
strains only affected the early life stages of the sea urchin embryos development, providing strong
evidence for the presence of compounds that interfere with growth factors on cells [11]. The organic
extracts of Synechococcus sp. LEGE11381 and Cyanobium sp. LEGE10375 exhibited interference with the
embryogenic development and also with the larval growth. From all the extracts tested, the organic
extract from Chroococcales 6MA13ti seemed to have the most potent effect on P. lividus larvae,
since it did not allow a normal development of any pluteus larvae. Cyanobium sp. organic extracts
have already been shown to decrease P. lividus larvae length [9]. Lopes, et al. [33] found organic
extracts from brackish waters to be more toxic to P. lividus, which is in accordance to our results.
The inhibition of larval morphogenesis, here observed, point to the presence of compounds that affect
skeleton formation.
Although hemolytic activity has already been documented in strains of Synechocystis [38],
Anabaena [39], Synechococcus and Leptolyngbya [40], our results showed that in neither organic nor
aqueous extracts analyzed, the lysis of the red mammalian blood cells was induced.
The present study aimed to assess a preliminary cyanotoxicological potential from twelve
marine cyanobacteria isolated from the sponges of the Portuguese coast. Eight extracts from
cyanobacterial strains have shown a promising potential on the performed ecologically-relevant
bioassays (Synechococcus sp. LEGE11381, Synechocystis sp. 44B13pa; Unidentified filamentous
Synechococcales LEGE11384; Phormidium sp. 25J12tp; Chroococcales 6MA13ti; Leptolyngbya sp. 31H12hpa;
Cyanobacterium 34C12sp; Cyanobium sp. LEGE10375). Furthermore, the concentrations of the extracts
here used (30 µg mL−1) are an ecologically relevant concentration. This emphasizes the premise that
sponges can harbor microorganisms with toxicological interest and that these invertebrates can and
should be used in order to isolate new cyanobacteria. The extracts with the most promising bioactivity
should be further fractionated to identify with more detail the bioactive compounds. Chemical
elucidation should be performed once the purest compounds are achieved.
4. Materials and Methods
4.1. Cyanobacterial Strains Selection and Biomass Production
Cyanobacterial strains used in this study were previously isolated from marine sponges. Marine
sponges were collected both from seashore rocks and by scuba diving. A small fraction of sponge
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tissue was collected in flaks with ambient seawater. Figure 5 shows sampling locations, being all
intertidal sites, with exception from the one in Madeira Island, Caniçal (sponges collected through
scuba diving). When collected from intertidal areas, beaches were chosen with a combination of sand
and rocks. Sponges substratum were rocks or sand. Preparation of sponge samples and cyanobacterial
isolation and characterization was done according to Regueiras, et al. [18]. Summarizing, sponges
were cleaned of debris and 1 mm of the sponge surface was discarded, using a sterile razor to avoid
cultivation of superficial bacteria. Small fragments of the sponge body (<0.5 cm3) were placed in 2
different culture media, Z8 liquid media [41], supplemented with 30 g L−1 of NaCl and MN liquid
medium [42]. Both culture media were supplemented with vitamin B12 and cyclohexamide [42].
After growth, through micromanipulation techniques, as described by Rippka [42], a single cell or
filament of cyanobacteria were transfer to new liquid medium, until achievement of unicyanobacterial,
non-axenic cultures.
1 
 
 
Figure 5. Sampling locations. Two sampling locations were in Portugal mainland: Memória
(N 41◦13′52.27”, W 8◦43′18.34”) and Porto Côvo (N 37◦52′3.04”, W 8◦47′37.19”). One was in Madeira
Island: Caniçal (N 32◦44′20.08”, W 16◦44′17.55”) and the other in São Miguel Island, Azores: São Roque
(N 37◦45′15,35”, W 25◦38′31.60”).
The selection of cyanobacterial strains was based on growth performance rates and cyanobacterial
diversity. Morphological identification followed the criteria of Komárek and Anagnostinis [43–45],
the Bergey’s manual of systematic bacteriology [46] and Komárek, et al. [47]. Strains are deposited in
the LEGE Culture Collection (Ramos et al., 2018). The twelve strains selected (Table 1) were cultured
and up-scaled under laboratory conditions at 25 ◦C, light/dark cycle of 14/10 h and light intensity
of approximately 25 × 10−6 E/m−2s−1. After 60 to 90 days of growth, the cyanobacterial biomass
produced was collected (through centrifugation or filtration with a 20 µm pore net), frozen at −20 ◦C
and freeze dried. Lyophilized material was kept at −20 ◦C.
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Table 1. Cyanobacterial strains selected for the present study, with information about the marine
sponge it was isolated from and collection site.
Cyanobacterial Strain Sponge Species Collection Site
Synechococcus sp. LEGE11381 Polymastia sp. Memória
Synechocystis sp. 44B13pa Polymastia agglutinans São Roque, Azores
cf. Phormidesmis sp. LEGE10370 Hymeniacidon perlevis Memória
Unidentified filamentous Synechococcales LEGE11384 Phorbas plumosus Memória
Phormidium sp. 25J12tp Tedania pilarriosae Memória
Nodosilinea cf. nodulosa LEGE10376 Hymeniacidon perlevis Porto Côvo
Chroococcales 6MA13ti Tedania ignis São Roque, Azores
Leptolyngbya sp. 31H12hpa Halichondria panicea Memória
Cyanobacterium 34C12sp Unidentified sponge Caniçal, Madeira
Cyanobium sp. LEGE10375 Hymeniacidon perlevis Memória
Pseudanabaena aff. curta 12C10hp Hymeniacidon perlevis Memória
Leptolyngbya sp. 31B12op Ophlitaspongia papila Memória
4.2. Preparation of Cyanobacterial Extracts
The freeze dried biomass from each cyanobacterial strain was repeatedly extracted with a warm
(<40 ◦C) mixture of dichloromethane and methanol (CH2Cl2:MeOH) (2:1) (P.A. Sigma, St Louis, MO,
USA). Afterwards, the solvents were removed in vacuo and/or under a N2 stream. Following the
organic extraction, the remaining biomass was subjected to aqueous extraction (ultra-pure water),
decanted, and centrifuged at 4600 rpm for 15 min. The resulting supernatant was freeze-dried,
weighed, and stored at −20 ◦C. Just before the tests, organic extracts were dissolved (30 mg mL−1) in
dimethyl-sulfoxide (DMSO) and aqueous extracts in ultra-pure water.
4.3. Bioassays
4.3.1. Acute Toxiciyy Assay Using Nauplii of Artemia Salina
In the acute toxicity assay, the nauplii of the crustacean Artemia salina were used. The dried cysts
(JBL Novotemia, Germany) hatched after 48 h in 35 g/L filtered seawater, at 25 ◦C, under conditions of
continuous illumination and aeration. Toxicity was screened in a 96-well polystyrene plate, with 10–15
nauplii per well and 200 µL of organic or aqueous extract. Filtered seawater with 0.1% DMSO was
used as negative control, and potassium dichromate at a concentration of 8 µg/mL as positive control.
Four replicates were made for each treatment. The plates were covered with Parafilm to prevent water
loss and then incubated at 25 ◦C, for 48 h in darkness. Dead larvae were counted in each well on an
inverted microscope at 24 h and 48 h. Before determining the total number of larvae, organisms were
fixed with a few drops of Lugol’s solution. Mortality was calculated through percentage as described
by Martins, et al. [11].
4.3.2. Embryo-Larval Acute Toxicity Assay with Paracentrotus Lividus
For the embryo-larval acute toxicity assay, sea urchins Paracentrotus lividus were captured in the
intertidal rocky shore, during low tide in Praia da Memória, Matosinhos, Portugal and immediately
transported to the laboratory, in natural sea water and under refrigeration. The protocol employed
was the one described by Fernández and Beiras [48]. Briefly, a couple of specimens were dissected,
and gametes were collected with a pipette directly from the gonads. The optimal condition from
gametes (spherical eggs and mobile sperm) was granted through careful observation under the optical
microscope. Eggs were transferred to a 100 mL measuring cylinder containing natural seawater filtered
through a 0.45 µm pore filter. A few microliters of sperm were added to the eggs suspension and
then carefully stirred to allow fertilization. Fertilized eggs were counted in four 10 µL aliquots in
order to determine the fertilization success and egg density. In a 24-well plate, a concentration of 20
fertilized eggs per mL of solution were exposed to organic and aqueous extracts, during 48 h at 20 ◦C,
in darkness. Test solutions consisted of 2.5 mL of each cyanobacterial extract; two negative controls
were used, one with only filtered seawater and the other with 0.1% DMSO; as positive control was used
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potassium dichromate in a concentration of 4 µg/mL. Four replicates were made for each treatment.
After 48 h of incubation, the solutions were fixed with 40% formalin. Results were evaluated through
percentage of pluteus larvae (embryogenic success) and larval length (larval growth) [11].
4.3.3. Hemolytic Assay
For the hemolytic assay, mice blood, stabilized with heparin, was provided by IBMC Bioterium,
from healthy specimens without need to sacrifice the animals. The protocol used was an adaptation of
the ones described by Rangel, et al. [49] and Slowing, et al. [50]. Summarizing, the erythrocytes solution
was diluted with 30 volumes of a saline solution (0.85% NaCl with 10 mM CaCl2) and centrifuged
at 1100 g for 5 min, discarding the supernatant and then washed three times with the same solution
followed by centrifugations (1100 g for 5 min). After the final wash, the cells were diluted to a final
concentration of 1% in sterile PBS solution. The assay was performed with 100 µL of each extract
mixed with equal volume of erythrocytes suspension, using three replicates per treatment. For the
negative and positive controls were used PBS and 0.1% Triton100, respectively. Eppendorfs with the
mixtures were incubated for 2 h, at a temperature of 37 ◦C, with slow agitation. After that period,
the mixtures were centrifuged at 4000 g for 1 min at 4 ◦C. The supernatants were transferred to a 96
well plate. Hemoglobin content was evaluated spectrophotometrically at 540 nm [49].
Hemolytic activity =
Abssample − Absnegative control
Abspositive control − Absnegative control × 100% (1)
4.3.4. Analysis
Data collected during the bioassays were analyzed using a one-way analysis of variance (ANOVA),
followed by a multi-comparisons Dunnett test (p < 0.05). The software IBM SPSS Statistics 24 (Version
24.0.0.0 edition 64-bit, IBM Corporation, New York, NY, USA, 2016) was used for statistical analysis.
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